Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
mBio ; 9(2)2018 04 03.
Artículo en Inglés | MEDLINE | ID: mdl-29615501

RESUMEN

Blastomyces dermatitidis is a human fungal pathogen of the lung that can lead to disseminated disease in healthy and immunocompromised individuals. Genetic analysis of this fungus is hampered by the relative inefficiency of traditional recombination-based gene-targeting approaches. Here, we demonstrate the feasibility of applying CRISPR/Cas9-mediated gene editing to Blastomyces, including to simultaneously target multiple genes. We created targeting plasmid vectors expressing Cas9 and either one or two single guide RNAs and introduced these plasmids into Blastomyces via Agrobacterium gene transfer. We succeeded in disrupting several fungal genes, including PRA1 and ZRT1, which are involved in scavenging and uptake of zinc from the extracellular environment. Single-gene-targeting efficiencies varied by locus (median, 60% across four loci) but were approximately 100-fold greater than traditional methods of Blastomyces gene disruption. Simultaneous dual-gene targeting proceeded with efficiencies similar to those of single-gene-targeting frequencies for the respective targets. CRISPR/Cas9 disruption of PRA1 or ZRT1 had a variable impact on growth under zinc-limiting conditions, showing reduced growth at early time points in low-passage-number cultures and growth similar to wild-type levels by later passage. Individual impairment of PRA1 or ZRT1 resulted in a reduction of the fungal burden in a mouse model of Blastomyces infection by a factor of ~1 log (range, up to 3 logs), and combined disruption of both genes had no additional impact on the fungal burden. These results underscore the utility of CRISPR/Cas9 for efficient gene disruption in dimorphic fungi and reveal a role for zinc metabolism in Blastomyces fitness in vivoIMPORTANCEBlastomyces is a human fungal pathogen that can cause serious, even fatal, lung infections. Genetic analysis of this fungus is possible but inefficient. We applied a recently developed gene editing technology, CRISPR/Cas9, to dramatically improve the efficiency with which gene disruptions are introduced into Blastomyces We used this system to disrupt genes involved in zinc uptake and found that this reduced the fitness of the fungus upon infection.


Asunto(s)
Blastomyces/crecimiento & desarrollo , Blastomyces/metabolismo , Edición Génica/métodos , Aptitud Genética , Zinc/metabolismo , Animales , Blastomyces/genética , Blastomicosis/microbiología , Proteína 9 Asociada a CRISPR/metabolismo , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Recuento de Colonia Microbiana , Modelos Animales de Enfermedad , Redes y Vías Metabólicas/genética , Ratones , ARN Guía de Kinetoplastida/metabolismo
2.
PLoS Pathog ; 13(8): e1006568, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28793349

RESUMEN

The development of vaccines against fungi and other intracellular microbes is impeded in part by a lack of suitable adjuvants. While most current vaccines against infectious diseases preferentially induce production of antibodies, cellular immunity is essential for the resolution of fungal infections. Microbes such as fungi and Mycobacterium tuberculosis require Th17 and Th1 cells for resistance, and engage the C-type lectin receptors including Dectin-2. Herein, we discovered a novel Dectin-2 ligand, the glycoprotein Blastomyces Eng2 (Bl-Eng2). Bl-Eng2 triggers robust signaling in Dectin-2 reporter cells and induces IL-6 in human PBMC and BMDC from wild type but not Dectin-2-/- and Card9-/- mice. The addition of Bl-Eng2 to a pan-fungal subunit vaccine primed large numbers of Ag-specific Th17 and Th1 cells, augmented activation and killing of fungi by myeloid effector cells, and protected mice from lethal fungal challenge, revealing Bl-Eng2's potency as a vaccine adjuvant. Thus, ligation of Dectin-2 by Bl-Eng-2 could be harnessed as a novel adjuvant strategy to protect against infectious diseases requiring cellular immunity.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Proteínas Fúngicas/inmunología , Vacunas Fúngicas/inmunología , Lectinas Tipo C/inmunología , Adyuvantes Inmunológicos/química , Animales , Blastomyces , Proteínas Fúngicas/química , Vacunas Fúngicas/química , Humanos , Lectinas Tipo C/metabolismo , Leucocitos Mononucleares/inmunología , Ligandos , Espectrometría de Masas , Ratones , Ratones Endogámicos C57BL , Micosis/inmunología , Micosis/prevención & control
3.
Cell Host Microbe ; 19(3): 361-74, 2016 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-26922990

RESUMEN

Systemic fungal infections trigger marked immune-regulatory disturbances, but the mechanisms are poorly understood. We report that the pathogenic yeast of Blastomyces dermatitidis elaborates dipeptidyl-peptidase IVA (DppIVA), a close mimic of the mammalian ectopeptidase CD26, which modulates critical aspects of hematopoiesis. We show that, like the mammalian enzyme, fungal DppIVA cleaved C-C chemokines and GM-CSF. Yeast producing DppIVA crippled the recruitment and differentiation of monocytes and prevented phagocyte activation and ROS production. Silencing fungal DppIVA gene expression curtailed virulence and restored recruitment of CCR2(+) monocytes, generation of TipDC, and phagocyte killing of yeast. Pharmacological blockade of DppIVA restored leukocyte effector functions and stemmed infection, while addition of recombinant DppIVA to gene-silenced yeast enabled them to evade leukocyte defense. Thus, fungal DppIVA mediates immune-regulatory disturbances that underlie invasive fungal disease. These findings reveal a form of molecular piracy by a broadly conserved aminopeptidase during disease pathogenesis.


Asunto(s)
Aminopeptidasas/metabolismo , Blastomyces/enzimología , Dipeptidil-Peptidasas y Tripeptidil-Peptidasas/metabolismo , Evasión Inmune , Tolerancia Inmunológica , Inmunidad Innata/efectos de los fármacos , Factores de Virulencia/metabolismo , Animales , Mimetismo Biológico , Blastomyces/patogenicidad , Quimiocinas/metabolismo , Dipeptidil-Peptidasas y Tripeptidil-Peptidasas/genética , Silenciador del Gen , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Macrófagos/inmunología , Ratones , Viabilidad Microbiana , Monocitos/inmunología , Fagocitosis , Especies Reactivas de Oxígeno/metabolismo , Homología de Secuencia de Aminoácido , Factores de Virulencia/genética
4.
mBio ; 6(5): e01403-15, 2015 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-26396244

RESUMEN

UNLABELLED: Blastomyces adhesin-1 (BAD-1) protein mediates the virulence of the yeast Blastomyces dermatitidis, in part by binding host lung tissue, the extracellular matrix, and cellular receptors via glycosaminoglycans (GAGs), such as heparan sulfate. The tandem repeats that make up over 90% of BAD-1 appear in their native state to be tightly folded into an inactive conformation, but recent work has shown that they become activated and adhesive upon reduction of a disulfide linkage. Here, atomic force microscopy (AFM) of a single BAD-1 molecule interacting with immobilized heparin revealed that binding is enhanced upon treatment with protein disulfide isomerase and dithiothreitol (PDI/DTT). PDI/DTT treatment of BAD-1 induced a plateau effect in atomic force signatures that was consistent with sequential rupture of tandem binding domains. Inhibition of PDI in murine macrophages blunted BAD-1 binding to heparin in vitro. Based on AFM, we found that a short Cardin-Weintraub sequence paired with a WxxWxxW sequence in the first, degenerate repeat at the N terminus of BAD-1 was sufficient to initiate heparin binding. Removal of half of the 41 BAD-1 tandem repeats led to weaker adhesion, illustrating their role in enhanced binding. Mass spectroscopy of the tandem repeat revealed that the PDI-induced interaction with heparin is characterized by ruptured disulfide bonds and that cysteine thiols remain reduced. Further binding studies showed direct involvement of thiols in heparin ligation. Thus, we propose that the N-terminal domain of BAD-1 governs the initial association with host GAGs and that proximity to GAG-associated host PDI catalyzes activation of additional binding motifs conserved within the tandem repeats, leading to enhanced avidity and availability of reduced thiols. IMPORTANCE: Pathogenic fungi and other microbes must adhere to host tissue to initiate infection. Surface adhesins promote this event and may be required for disease pathogenesis. We studied a fungal adhesin essential for virulence (BAD-1; Blastomyces adhesin-1) and found that host products induce its structural reconfiguration and foster its optimal binding to tissue structures.


Asunto(s)
Blastomyces/fisiología , Proteínas Fúngicas/metabolismo , Glicosaminoglicanos/metabolismo , Proteína Disulfuro Isomerasas/metabolismo , Factores de Virulencia/metabolismo , Animales , Ditiotreitol/metabolismo , Ratones , Microscopía de Fuerza Atómica , Oxidación-Reducción , Unión Proteica , Virulencia
5.
Cell Host Microbe ; 17(4): 452-65, 2015 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-25800545

RESUMEN

Fungal infections remain a threat due to the lack of broad-spectrum fungal vaccines and protective antigens. Recent studies showed that attenuated Blastomyces dermatitidis confers protection via T cell recognition of an unknown but conserved antigen. Using transgenic CD4(+) T cells recognizing this antigen, we identify an amino acid determinant within the chaperone calnexin that is conserved across diverse fungal ascomycetes. Calnexin, typically an ER protein, also localizes to the surface of yeast, hyphae, and spores. T cell epitope mapping unveiled a 13-residue sequence conserved across Ascomycota. Infection with divergent ascomycetes, including dimorphic fungi, opportunistic molds, and the agent causing white nose syndrome in bats, induces expansion of calnexin-specific CD4(+) T cells. Vaccine delivery of calnexin in glucan particles induces fungal antigen-specific CD4(+) T cell expansion and resistance to lethal challenge with multiple fungal pathogens. Thus, the immunogenicity and conservation of calnexin make this fungal protein a promising vaccine target.


Asunto(s)
Antígenos Fúngicos/inmunología , Ascomicetos/inmunología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Calnexina/inmunología , Proliferación Celular/efectos de los fármacos , Epítopos/inmunología , Animales , Ratones
6.
J Med Assoc Thai ; 97(3): 342-8, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25123015

RESUMEN

BACKGROUND: The fungus-like organism Pythium insidiosum is the causative agent of a life-threatening tropical infectious disease, pythiosis, which has high rates of morbidity and mortality. A lack of reliable diagnostic tools and effective treatments for pythiosis presents a major challenge to healthcare professionals. Unfortunately, surgical removal of infected organs remains the default treatment for pythiosis. P. insidiosum is an understudied organism. In-depth study of the pathogen at the molecular level could lead to better means of infection control High quality genomic DNA (gDNA) is needed for molecular biology-based research and application development, such as: PCR-assisted diagnosis, population studies, phylogenetic analysis, and molecular genetics assays. OBJECTIVE: To evaluate quality and quantity of the P. insidiosum gDNA extracted by three separate protocols intended for fungal gDNA preparation. MATERIAL AND METHOD: Seven P. insidiosum isolates were subjected to gDNA extraction by using conventional-extraction, rapid-extraction, and salt-extraction protocols. RESULTS: The conventional protocol offered the best gDNA in terms of quality and quantity, and could be scaled up. The rapid-extraction protocol had a short turnaround time, but the quality and quantity of the gDNA obtained were limited. The salt-extraction protocol was simple, rapid, and efficient, making it appealing for high throughput preparation of small-scale gDNA samples. CONCLUSION: Compared to rapid-extraction protocol, both conventional-extraction and salt-extraction protocols provided a better quality and quantity of gDNA, suitable for molecular studies of P. insidiosum. In contrast to the other two methods, the salt-extraction protocol does not require the use of hazardous and expensive materials such as phenol, chloroform, or liquid nitrogen.


Asunto(s)
ADN/aislamiento & purificación , Pythium/genética , Animales , Genoma , Humanos , Reacción en Cadena de la Polimerasa/métodos , Pitiosis/genética , Pythium/clasificación , Pythium/aislamiento & purificación
7.
Diagn Microbiol Infect Dis ; 76(1): 42-5, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23537786

RESUMEN

Pythiosis is a life-threatening infectious disease caused by the fungus-like organism Pythium insidiosum. Morbidity and mortality rates of pythiosis are high. The treatment of choice for pythiosis is surgical debridement of infected tissue. Early and accurate diagnosis is critical for effective treatment. In-house serodiagnostic tests, including immunodiffusion (ID), enzyme-linked immunosorbent assay (ELISA), immunochromatography (ICT) and hemagglutination (HA) have been developed to detect antibodies against P. insidiosum in sera. This study compares the diagnostic performance of ID, ELISA, ICT, and HA, using sera from 37 pythiosis patients and 248 control subjects. ICT and ELISA showed optimal diagnostic performance (100% sensitivity, specificity, positive predictive value and negative predictive value). ICT was both rapid and user-friendly. ELISA results were readily quantitated. ID is relatively insensitive. HA was rapid, but diagnostic performance was poor. Understanding the advantages offered by each assay facilitates selection of an assay that is circumstance-appropriate. This will promote earlier diagnoses and improved outcomes for patients with pythiosis.


Asunto(s)
Anticuerpos Antifúngicos/sangre , Antígenos Fúngicos/sangre , Hemaglutinación , Pitiosis/diagnóstico , Pythium/inmunología , Pruebas Serológicas/métodos , Cromatografía de Afinidad/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Inmunodifusión/métodos , Pitiosis/microbiología , Pythium/aislamiento & purificación , Sensibilidad y Especificidad
8.
Artículo en Inglés | MEDLINE | ID: mdl-21329324

RESUMEN

Pythium insidiosum causes a potentially life-threatening infectious disease called pythiosis. An early, accurate diagnosis is important, since prompt treatment leads to a better prognosis. Unsuccessful attempts to isolate the organism have been associated with specimens subjected to lower temperatures. We analyzed growth of P. insidiosum at various temperatures. Culture at low (8 degrees C) and high (42 degrees C) temperatures resulted in death or inhibited growth of the organism. Culture under optimal temperatures (28 and 32 degrees C) was important for successful isolation of P. insidiosum.


Asunto(s)
Frío , Calor , Pythium/crecimiento & desarrollo , Humanos , Pythium/aislamiento & purificación
9.
Med Mycol ; 44(1): 41-9, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16805092

RESUMEN

The adhesin BAD1 is required for virulence of Blastomyces dermatitidis in a pulmonary model of infection. Herein, we explored mechanisms by which BAD1 enhances pathogenicity of the fungus. Isogenic strains with and without BAD1 exhibited similar phenotypic differences in virulence by pulmonary and intravenous routes of infection, indicating that BAD1 may exert virulence beyond adherence to respiratory lining cells. Non-adhesive mechanisms including maintenance of intrinsic resistance of yeast against phagocyte responses and products were excluded. A shift in the balance of type 1 and 2 cytokines and in the cellular profile of the inflammatory response after the first week of pulmonary infection was associated with BAD1. By the second week of infection, infection with wild-type yeast was associated with less IL-12 and IFN-gamma, and more IL-10, and an influx of inflammatory cells rich in neutrophils and poor in T-cells, when compared to infection with the BAD1 null strain. Taken together with previously reported BAD1 perturbations of TNF-gamma and TGF-beta, these data suggest that BAD1 contributes significantly to the pathogenicity of B. dermatitidis by also deviating host adaptive immunity, and leukocyte responses.


Asunto(s)
Blastomyces/patogenicidad , Blastomicosis/microbiología , Proteínas Fúngicas/fisiología , Glicoproteínas/fisiología , Enfermedades Pulmonares Fúngicas/microbiología , Factores de Virulencia/fisiología , Animales , Blastomyces/genética , Blastomicosis/inmunología , Recuento de Colonia Microbiana , Modelos Animales de Enfermedad , Proteínas Fúngicas/genética , Eliminación de Gen , Glicoproteínas/genética , Histocitoquímica , Humanos , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Interleucina-12/biosíntesis , Pulmón/inmunología , Pulmón/patología , Enfermedades Pulmonares Fúngicas/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Neutrófilos/inmunología , Factores de Virulencia/genética
10.
Mol Microbiol ; 48(1): 53-65, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12657044

RESUMEN

BAD1, an adhesin and immune modulator of Blastomyces dermatitidis, is an essential virulence factor that is released extracellularly before association with the yeast surface. Here, deletion of the C-terminal EGF-like domain profoundly affected BAD1 function, leading to non-association with yeast, extracellular accumulation and impaired yeast adherence to macrophages. In equilibrium binding assays, DeltaC-term BAD1, lacking an EGF-like domain, bound poorly to BAD1 null yeast, yielding a low affinity (Kd, 3 x 10(-7) M versus 5 x 10(-8) M) and Bmax (1.9 x 10(5) versus 7.9 x 10(5)) compared with BAD1. Similar protein binding profiles were observed using chitin particles, reinforcing the notion that chitin fibrils are a receptor for BAD1, and that the EGF-like domain is critical for BAD1 interactions with chitin on yeast. DeltaC-term strains bound poorly to macrophages, compared with parental or BAD1-reconstituted null strains. However, DeltaC-term strains and the purified protein itself sharply suppressed tumour necrosis factor (TNF)-alpha release by phagocytes in vitro and in lung in vivo, and the strains retained pathogenicity in a murine model of blastomycosis. Our results illustrate the previously undefined role of the EGF-like domain for BAD1 localization to yeast surfaces during cell wall biogenesis. They also demonstrate that the requirements for host cell binding and immune modulation by BAD1 can be dissociated from one another, and that the former is unexpectedly dispensable in the requisite role of BAD1 in pathogenesis.


Asunto(s)
Blastomyces/inmunología , Blastomyces/patogenicidad , Factor de Crecimiento Epidérmico/metabolismo , Proteínas Fúngicas , Glicoproteínas/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Blastomyces/metabolismo , Cartilla de ADN , Factor de Crecimiento Epidérmico/química , Masculino , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Virulencia
11.
Microbiology (Reading) ; 142 ( Pt 6): 1551-1556, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8704996

RESUMEN

The fungus-feeding beetle, Carpophilus freemani, consumed equal quantities of young mycelia, fewer phialides bearing mature spores and much fewer phialides bearing developing spores of Aspergillus restrictus compared to those of Aspergillus nidulans when tested in diet choice assays. The degree to which specific fungal structures were consumed was inversely related to the localization of high levels of restrictocin, a ribosome-inactivating protein, to those structures. Pure restrictocin added to the insect diet at 1000 p.p.m. killed 38.5% of C. freemani larvae and 62.5% of Spodoptera frugiperda larvae in 48 h, but did not affect C. freemani adults or Helicoverpa zea larvae over the same interval. In diet choice assays, 1000 p.p.m. of restrictocin deterred feeding by adult C. freemani and Sitophilus zeamais compared to control diets. Thus, restrictocin production and localization may have a natural defensive role against insect feeding at times critical to spore formation by A. restrictus, and may have potential as an insect control agent.


Asunto(s)
Alérgenos , Aspergillus/química , Escarabajos/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Proteínas Fúngicas/farmacología , Ribonucleasas/farmacología , Animales , Antígenos de Plantas , Aspergillus/crecimiento & desarrollo , Escarabajos/crecimiento & desarrollo , Escarabajos/fisiología , Depresión Química , Proteínas Fúngicas/toxicidad , Larva , Mariposas Nocturnas/efectos de los fármacos , Mariposas Nocturnas/crecimiento & desarrollo , Control Biológico de Vectores , Ribonucleasas/toxicidad , Spodoptera/efectos de los fármacos , Spodoptera/crecimiento & desarrollo , Esporas Fúngicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA